Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Biotech Company, ENDV Should Be On Everyone's Watchlist
From ACCESSWIRE
Innovative Biotech Companies Pushing the Envelope
From PR Newswire
41 Biggest Movers From Yesterday
Gainers Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging ... 
Tags RDVT BSQR VKTX
From Benzinga
Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.29 percent to 24,778.96 while the NASDAQ climbed 0.69 percent to 7,402.60. The ... 
Tags ABAX Market News Department Stores
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of ... 
Tags STKS Department Stores ENPH
From Benzinga
Mid-Day Market Update: Abaxis Climbs On Acquisition News; Evolus Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.12 percent to 24,734.97 while the NASDAQ climbed 0.44 percent to 7,383.79. The ... 
Tags Market News ABAX IPI
From Benzinga
26 Stocks Moving In Wednesday's Pre-Market Session
Gainers Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported ... 
Tags XENE TEVA CYAD
From Benzinga
Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags News BIOC INSP
From Benzinga
Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio
Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a late-stage clinical company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of cancer, today announced that the... 
From Business Wire News Releases
Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a late-stage clinical company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of cancer, today reported pipeline... 
From Business Wire News Releases
BRIEF-Eleven Biotherapeutics Files Prospectus Relates To Resale By Selling Stockholders Of Up To 7.97 Mln Shares
* ELEVEN BIOTHERAPEUTICS INC FILES PROSPECTUS RELATES TO RESALE BY SELLING STOCKHOLDERS OF UP TO 7.97 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text: (https://bit.ly/2IeZIDy) Further... 
Tags companyNews
From Reuters: Company News
Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags IBB MOR EXEL
From Benzinga
Stock Review for Biotech's Investors -- BioTime, Eleven Biotherapeutics, Endocyte, and Esperion Therapeutics
From PR Newswire
Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags NVS COCP Earnings
From Benzinga
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags Top Stories SPHS Earnings
From Benzinga
Market Trends Toward New Normal in Emerge Energy Services LP, NACCO Industries, 8x8, Eleven Biotherapeutics, Monolithic Power, and Highwoods Properties — Emerging Consolidated Expectations, Analyst Ra
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Emerge Energy Services LP... 
From GlobeNewswire News Releases
36 Biggest Movers From Yesterday
Gainers SteadyMed Ltd. (NASDAQ: STDY) surged 77.36 percent to close at $4.70 on Monday after United Therapeutics Corporation ... 
Tags FATE Movers & Shakers Markets
From Benzinga
36 Stocks Moving In Monday's Mid-Day Session
Gainers SteadyMed Ltd. (NASDAQ: STDY) climbed 78.3 percent to $4.725 after United Therapeutics Corporation (NASDAQ: UTHR) ... 
Tags CHEK PJC FRED
From Benzinga
9 trade ideas for next week
Tags NVUS SRRA SPHS
From AC Investor Blog
35 Stocks Moving In Friday's Mid-Day Session
Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy ... 
Tags NATI ZYME ELOX
From Benzinga
24 Stocks Moving In Friday's Pre-Market Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 15.3 percent to $2.41 in pre-market trading after declining 25.09 percent ... 
Tags FLEX SNE #PreMarket Gainers
From Benzinga
Benzinga's Daily Biotech Pulse: Catabasis Soars On Trial Results, Eloxx Listing, Biomarin Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags CATB RSLS Biotech
From Benzinga
Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks Hitting ... 
Tags Movers MDCO AMGN
From Benzinga
Biotech Drug Production Pipeline Increasing Amid Buzz of Market Optimism
From PR Newswire
Ten trade ideas for next week
Tags EBIO SAEX SKYS
From AC Investor Blog
New Preclinical Data Highlighting Eleven Biotherapeutics’ DeBouganin Program to be Presented at 2018 AACR Annual Meeting
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a late-stage clinical company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of cancer, today announced that... 
From Business Wire News Releases
BRIEF-Eleven Biotherapeutics Reports Q4 Loss Per Share $0.22
* ELEVEN BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 OPERATING RESULTS AND VICINIUM DEVELOPMENT PROGRESS 
Tags companyNews
From Reuters: Company News
Eleven Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Operating Results and Vicinium Development Progress
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a late-stage clinical company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of cancer, today reported key pipeline... 
From Business Wire News Releases
Small Cap to Large Cap Pharma Companies Positioning to Capitalize on Resurgent Biotech Industry
From PR Newswire
BRIEF-Eleven Biotherapeutics To Present Early Data From Bladder Cancer Trial In May
* PRELIMINARY DATA FROM PHASE 3 VISTA TRIAL IN BLADDER CANCER TO BE PRESENTED IN A PLENARY SESSION AT AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING 
Tags companyNews
From Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.